Several overlapping chromosomal deletis sning the albino locus in the mouse cause perinatal lethality when homozygous and a block in the trnscriptional Induction of various unlinked hepatocyte-specific genes. Studies of such lethal albino deletion homozygotes in perinatal stages revealed a deficiency in the transcriptional inducibility of the tyrosine aminotrnsferase (TAT) gene by glucocorticolds; yet, glucocorticoid receptor and hormone levels were shown to be uected.
deficiency in the transcriptional inducibility of the tyrosine aminotrnsferase (TAT) gene by glucocorticolds; yet, glucocorticoid receptor and hormone levels were shown to be uected.
To identify a molecular defect underlying the failure of i ble expression, we examine the chromatin structure of the TAT gene. Whereas in wild-type animals the TAT promoter becomes DNase I hypersensitive at birth, such hypersensitivity falls to develop in lethal albino deletion homozygotes. By contrast, the deletions do not affect the appearance of three DNase I-hypersensitive sites upstream ofthe TAT promoter in the liver, nor do they affect two hypersensitive sites upstream of the expressed a-fetoprotein gene. These fings demonstrate that the abnormality of chromatin structure identified in lethal albino deletion homozygotes occurs on a highly selective basis. Specifically, normal differentiation of the TAT promoter chromatin appears to depend directly or indirectly on the action and product of a gene mapping within the deleted region.
Cell type-specific abnormalities of differentiation at both the molecular and ultrastructural levels are caused by overlapping deletions around the albino locus on chromosome 7 of the mouse and result in perinatal lethality (1, 2) . In particular, the developmental induction of unlinked hepatocyte-specific genes, such as that encoding tyrosine aminotransferase (TAT) (3) , is affected by the lethal albino deletions, as expressed in the deficiency of transcriptional inducibility of these genes in the liver at birth (4) (5) (6) (7) . Normally, the action of endogenous or exogenous glucocorticoid hormone at the time of birth results in inducible expression of TAT and several other liver-specific genes; in albino deletion homozygotes, the induction of these genes by the hormone is blocked (3, 7) . Recent studies have shown that the steady-state levels of glucocorticoid receptor mRNA and protein are not affected in the lethal albino deletions and that the association of the receptor with the heat shock protein hsp90 remains normal (8) . Also, no significant differences were found between glucocorticoid hormone levels of normal and homozygous albino deletion newborns (8) . Therefore, in lethal albino deletion homozygotes the competence of genes to respond to glucocorticoid induction appears to be affected rather than elements in the signal transduction pathway itself.
Increasing evidence indicates that the configuration of chromatin plays an important role in the mechanism of transcriptional activation (9) . In the chromatin of higher eukaryotes, virtually all regulatory sequences-such as those of promoters, enhancers, and locus control regions-show DNase I hypersensitivity when the relevant elements are active (10) . Nuclease hypersensitivity is thought to be due to altered DNA structures or to specific DNA binding proteins that perturb or displace a nucleosome, rendering the adjacent sequences available for nuclease attack (11, 12) . For example, in vivo and in vitro footprinting studies have shown that binding of the glucocorticoid receptor (13) and a liverenriched transcription factor (14) disrupt a nucleosome (15) at a DNase I-hypersensitive site 2.5 kilobase pairs (kbp) upstream of the rat TAT promoter (16) and that the DNA segment at this site can function autonomously as a glucocorticoid response element (13) . Nuclease-hypersensitive sites have also been detected in hepatocyte chromatin 3.6 and 11 kbp upstream of the rat TAT promoter, and both of these sites function independently as enhancer elements in hepatocyte-derived cell lines (17) .
Assuming that nuclease hypersensitivity reflects the functional state of regulatory sequences, we investigated the effects ofthe lethal albino deletions when homozygous on the chromatin structure of the mouse TAT gene. We therefore identified DNase I-hypersensitive sites upstream of the mouse TAT gene and examined the appearance of hypersensitivity during development. Subsequently, a perturbation in the formation of one particular hypersensitive site present in normal newborn mice was discovered in littermates homozygous for the lethal albino deletions. These (19) of the procedure of Lichtsteiner et al. (20) , as for the samples shown in Figs. 3 and 4 . Nuclei prepared by either method were suspended on ice at a concentration of 10 A260 units/mi. One-fifth of the total sample was lysed immediately by adding a stop solution containing SDS, NaCl, and proteinase K as described (21) . One-fifth of the total sample was warmed to 370C, further incubated for 3 min, and then lysed as a control for endogenous nuclease activity. The remaining nuclei were warmed to 370C, DNase I was added (see figure legends for final concentrations), and samples were removed for lysis after 30 sec, 1 min, and 3 min.
Genomic DNA was purified from lysed samples and subjected to Southern blot analysis as described (21) .
DNA Hybridization Probes. All TAT probes were derived from the plasmid pmTAT-SH3.7 (22) , which contains the Sal I/HindIII genomic fragment spanned by probe B (see Fig. 1 ). Probes A and B were labeled by nick-translation; the 90-bp probe C was labeled with [y-32P]ATP and polynucleotide kinase. The EcoRI/Cla I fragment used to probe a-fetoprotein chromatin has been described (23) .
RESULTS
DNase I Hypersensitivity of the Mouse TAT Promoter in Normal and Lethal Albino Deletion Homozygous Mice. Previous studies of the rat TAT promoter showed it to be strongly DNase I hypersensitive in hepatocytes (17) ; we therefore examined the chromatin structure of the mouse TAT promoter as a positive control for our assay. Hepatocyte nuclei were prepared from normal adult heterozygous females and treated with DNase I; the resulting DNA samples were analyzed by the indirect end-labeling procedure (24) . Genomic DNA was digested with HindIII, fractionated by gel electrophoresis, blotted to nitrocellulose, and hybridized to the EcoRI/HindIII probe A as schematized in Fig. 1 . In addition to the expected 5.7-kbp genomic HindIII fragment, an abundant subfragment appeared due to cleavage at the TAT promoter at about -0.1 kbp from the transcription start site (Fig. 2, lanes 3 and 4) . The -0.1-kbp subband was seen in all nuclear samples incubated at 37°C, with or without added DNase I (lane 2), but it was absent in samples not warmed to 37°C (control DNA; lane 1), demonstrating that cleavage at the TAT promoter was due to nuclease digestion of chromatin. However, the much faster appearance of the -0.1-kbp subband in the DNase I-treated samples demonstrates that the enzyme cleaves specifically at the promoter region in chromatin. In conclusion, the mouse TAT promoter, like the rat TAT promoter, is strongly nuclease sensitive in normal adult hepatocyte chromatin. and an EcoRI (partial digest)/Hindll fragment (lower subband) from the TAT gene (see Fig. 1 ). The -0.1 subband in nuclease samples migrates slightly faster than the latter fragment, demonstrating that the -0.1 hypersensitive site maps at the TAT promoter. The more slowly migrating subband in lane 3 is due to cross-hybridization to nonspecific genomic sequences, as verified by various probing experiments.
TAT DNase I-hypersensitive sites gave rise to subbands that appeared faint in the perinatal liver samples, presumably because at that developmental stage the liver is primarily a hematopoietic organ with hepatocyte nuclei representing only~40% of the total number of nuclei (25) . Nevertheless, the mouse TAT promoter, which is active at birth, was found to be DNase I hypersensitive in normal newborn animals (Fig. 2, lanes 7-9) . The presence of an internal control marker on the same gel, which cleaves at an EcoRI site 205 bp upstream of the TAT transcription start site, made possible Proc. Natl. Acad. Sci. USA 89 (1992) a precise localization of the -0.1-kbp DNase I-hypersensitive site in the TAT promoter. In contrast, the TAT promoter was not hypersensitive in liver nuclei of C3H/C3H homozygous deletion mice (lanes [11] [12] [13] , where the promoter is much less active (26) .
To determine whether the deficiency of hypersensitivity at the TAT promoter in cJH/c3H was also seen in CJ4coS albino deletion homozygotes, we performed the experiment shown in Fig. 3 . The bands in this figure are displayed by hybridization to probe B (see Fig. 1 ), which anneals to both subfragments generated by nuclease cleavage of the 5.7-kbp HindIII fragment. When the normal adult liver samples shown in Fig. 2 were hybridized to probe B, the original -0. 1-kbp subband and a new, more slowly migrating subband became evident (Fig. 3, lanes 2-4) ; its size was consistent with its end points at the upstream HindIII site and the TAT promoter (Fig. 1) (Fig. 3, lanes 15-23) . Other DNase I-hypersensitive sites were present in these fetal chromatin samples (see below), demonstrating the specificity ofthe lack of hypersensitivity at the TAT promoter. We conclude that nuclease hypersensitivity at the -0.1-kbp hypersensitive site normally appears at birth, correlated with the increase in TAT gene expression. In homozygous deletion mice, hypersensitivity at the -0.1-kbp site fails to develop concomitantly with a deficiency in TAT transcription.
Upstream TAT Sites Become DNase I Hypersensitive During Fetal Development and Are Not Affected in Albino Deletion
Homozygotes. The presence of nuclease-hypersensitive sites upstream of the rat TAT promoter (17) suggested that such sites might also be found upstream of the mouse promoter. Chromatin samples were digested with Stu I, fractionated by gel electrophoresis, transferred to nitrocellulose, and hybridized to the Sac I/Stu I probe C as shown in Fig. 1 . The 90-bp probe C is short enough to allow accurate mapping of upstream hypersensitive sites. In addition to the expected genomic Stu I fragment of =20 kbp, the autoradiograph displayed subbands due to nuclease cleavage in adult hepatocyte chromatin 7.9 and 11 kbp upstream of the TAT transcription start site (Fig. 4, lanes 1-3) . Subbands marked by asterisks in Fig. 4 were present consistently in nuclear samples not warmed to 37°C and therefore are apparently the result of cross-hybridization to other genomic sequences. Also, a larger probe, which extended from the Stu I site to the upstream Sal I site, hybridized to these and many other genomic fragments under stringent hybridization conditions (data not shown), indicating the presence of a repeated sequence element. By contrast, the subbands marked by arrows in Fig. 4 were consistently detected by probe C in nuclear samples warmed to 37°C for 3 min, and they appeared much faster in the presence of DNase I, indicating that they were generated by the presence of nuclease-hypersensitive sites. The -7.9-and -11-kbp hypersensitive sites were evident in normal mice in both late fetal and newborn stages of hepatocyte development (Fig. 4 , lanes 4-6 and 10-12). A subband due to cleavage at -4.1 kbp was also seen in normal fetal samples but was fainter in newborn and almost undetectable in adult samples. All of these hypersensitive sites were present in hepatocyte chromatin of Cl4CoS/C14CoS homozygous albino deletion mice at late fetal and newborn stages (lanes 7-9 and 13-15). We conclude that three sites become hypersensitive upstream ofthe TAT promoter during fetal development of both normal mice and deletion homozygotes but that hypersensitivity at the promoter site develops at birth in normal mice and fails to appear in lethal albino homozygotes. These findings are summarized in Table 1 .
Albino Deletion Homozygotes Exhibit Normal Chromatin Structure of the a-Fetoprotein Gene. To address further the selectivity of the effect of lethal albino deletions on hepatocyte chromatin structure, we examined the nuclease sensitivity of two enhancer elements residing upstream of the a-fetoprotein gene. Previous studies had shown the levels of mRNA for a-fetoprotein to be undiminished in the livers of newborn albino Cl4Cos deletion homozygotes (4) . As shown in DNase I hypersensitivity at the TAT promoter is induced at birth. Analysis of liver nuclear DNA samples was similar to Fig. 2 except that the DNAs were hybridized to the Sal I/HindIII probe B (see Fig. 1 ). Maternal samples (lanes [1] [2] [3] [4] [5] were the same as shown in Fig. 2 . Lanes 1, 6, and 15 (0), DNA from nuclear samples lysed without prewarming to 37°C. Liver nuclei warmed to 37°C (+) were treated as follows: lanes 2, 7, 11, 16, and 20, without added DNase I for 3 min; lanes 8-10 and 12-14, with DNase I at 1 ug/ml; lanes 17-19 and 21-23, with DNase I at 3 jig/ml for 30 sec (lanes 8, 12, 17, and 21), 1 min (lanes 9, 13, 18, and 22), or 3 min (lanes 10, 14, 19, and 23) . The probe detects both subbands generated by DNase I cleavage at the TAT promoter (-0.1; open arrows) . Other bands present are due to cross-hybridization of the probe to nonspecific genomic sequences. Fig. 2 except that they were hybridized to the radiolabeled Sac I/Stu I probe C (Fig. 1) . The newborn and fetal samples were taken from the DNase I-treated samples shown in Fig.  3 , whereas the maternal sample was treated differently. Lane 1, maternal nuclear sample lysed without prewarming to 370C; lanes 2 and 3, nuclei at 37C (+) in the absence of added nuclease for 5 min (lane 2) or in the presence of DNase I at 3 jtg/ml for 30 sec (lane 3).
The probe detects subbands (open arrows) generated by DNase I cleavage at -11, -7.9, and -4.1 kbp with respect to the TAT transcription start site. In some experiments, DNase I hypersensitivity was observed at a site between the -7.9-and -11-kbp sites. Probe C often gave rise to bands (asterisks) that were visible in nuclease samples and samples that were lysed without warming to 37rC (data not shown); these are likely to be due to hybridization to nonspecific genomic sequences. Fig. 5 (lanes 1-4) , normal newborn mice exhibit nuclease hypersensitivity at the EI and EII a-fetoprotein enhancers (27) , similar to that observed in an earlier study (27, 28) . Importantly, both enhancers are also hypersensitive in the C3H/c3H deletion homozygous newborn mice (lanes 5-8). The albino deletions therefore affect liver chromatin with a high degree of selectivity, perturbing the formation of a hypersensitive site only at the TAT promoter and not at five other hypersensitive sites tested here.
DISCUSSION
The studies reported here concern further molecular investigations of the failure of the TAT gene to be transcriptionally induced at birth in c3H and cl4cos albino deletion homozygotes. This system serves as a model for identification of possible molecular defects associated with the failure of a specific cluster of hepatocyte-specific genes to show normal inducible expression in newborn deletion homozygotes. Nuclease-hypersensitive sites were detected 4.1, 7.9, and 11 kbp upstream of the TAT promoter in the chromatin of normal hepatocytes. The three sites were hypersensitive in nuclei of fetuses prior to the induction of TAT transcription, and the homozygous lethal albino deletions had no effect on the E IEI 1 2 3 4 5 6 7 8
FIG. 5. Hypersensitive sites upstream of the a-fetoprotein gene are not affected in lethal albino deletion homozygotes. Analysis of the newborn liver nuclear DNA samples was the same as for that shown in Fig. 2 , except that the DNAs were digested with EcoRI and hybridized to a 1-kbp EcoRI/CIa I fragment upstream of the a-fetoprotein gene (23) . Open arrows show the positions of subbands due to cleavage at the upstream enhancers El and ElI. The lane-to-lane variation in intensity of the subbands was also seen in a previous study (23) . The subbands below the ElI subbands were not seen consistently.
appearance of these sites. In contrast, the chromatin of the TAT promoter itself was not nuclease hypersensitive in late fetal stages of normal mice, but hypersensitivity appeared in perinatal stages. Thus, in the case of the TAT promoter, as shown for numerous other inducible regulatory elements (10), the appearance of nuclease hypersensitivity coincides with increased gene activity. Strikingly, both the appearance of TAT promoter hypersensitivity and transcriptional inducibility are missing in albino deletion homozygotes. The present results indicate that the failure of TAT inducibility in deletion homozygotes is not due to a complete perturbation of TAT chromatin structure. This conclusion is consistent with the fact that TAT transcription does in fact continue in the mutants even though at a low basal level (3, 5, 6, 26) . Also, hypersensitive sites at enhancers of the a-fetoprotein gene were shown to be unaffected in the deletion homozygotes, further demonstrating the specificity of the effect found in TAT chromatin. Moreover, the perinatal development of nuclease hypersensitivity at the TAT promoter in normal animals appears to identify a change in chromatin structure critical for normal transcriptional induction of the TAT gene at birth. All of this leads to the suggestion that a factor(s), possibly gene products normally encoded in the deleted region and deficient in the deletion homozygotes, plays an essential role in a chain of events leading to this change of chromatin structure.
When speculating about the possible mechanisms underlying the normal perinatal changes in the TAT promoter chromatin structure, it is important to note that this promoter had acquired hypersensitivity to both exogenous DNase I and an endogenous nuclease, indicating that the DNA had been Genetics: Zaret et al.
Proc. Natd. Acad. Sci. USA 89 (1992) exposed to distinct probes. A comparison with other systems (10, 11, 12) suggests that such nuclease hypersensitivity may reflect a disruption or loss of local nucleosome structure, presumably due to the binding of trans-acting factors. The absence of such nuclear factors in the albino deletion homozygotes, and therefore their failure to alter the chromatin structure of the TAT promoter, may be responsible for the inability of the promoter to become inducible at birth. Previous studies showed that administration of glucocorticoids to albino deletion homozygous newborns did not enhance the inducibility of TAT transcription (3) but that the signal transduction pathway for the steroid appeared to be unaffected (8) . In the rat, a glucocorticoid response element (GRE) resides 2.5 kbp upstream of the TAT promoter, and the sequence becomes DNase I hypersensitive in mature hepatocytes as a result of hormone administration (16) . Detailed studies have shown that hormone stimulation causes the glucocorticoid receptor and additional binding factors (13, 14) to disrupt a nucleosome at the -2.5-kbp site (15) , resulting in an active GRE (29) . The rat TAT promoter does not appear to bind the glucocorticoid receptor, and it requires the upstream GRE for hormonal regulation (13) . Since the mouse and rat TAT promoter sequences are virtually identical (22) , it seems unlikely that hypersensitivity at the mouse TAT promoter at birth would be due to direct binding of the glucocorticoid receptor. Rather, nuclease hypersensitivity might reflect binding of the receptor to a site upstream, and a regulatory gene product deleted in the cH and C14CoS homozygous mice might be required for the purpose of making the promoter competent to respond to the inducing signal. Another possibility is that hypersensitivity at the promoter could be a consequence of the regulatory gene product acting directly at a distal upstream site. A thorough understanding of TAT gene regulation awaits a developmental study and a definition of the glucocorticoid-responsive sequences in the mouse. The chromatin abnormality identified in a gene affected by the albino deletions represents at this time the strongest evidence for the existence of a trans-acting factor essential for normal differentiation of the affected target genes. The analysis of a molecular defect associated with the abnormalities of TAT expression and inducibility reported here raises the question of identical effects of the deletions on the chromatin of the other similarly affected genes encoding gluconeogenic liver enzymes (1, 6) .
Recent chromosome mapping experiments (30) have shown that the gene encoding fumarylacetoacetate hydrolase (FAH) is included in the lethal albino deletions, which, in addition to their effects on inducible expression of certain liver genes, had been shown earlier to cause abnormalities of the ultrastructure of particular organelles of hepatocytes and kidney tubules (1) . FAH catalyzes the terminal step in tyrosine catabolism, and a deficiency in this enzyme in humans has been reported to cause tyrosinemia type 1 (31) . The disease is marked by accumulation of a toxic metabolic derivative of tyrosine, depletion ofglutathione, and inhibition of S-adenosylmethionine synthetase (31) . Similar metabolic abnormalities caused by the absence of FAH might be suspected to be responsible for some of the effects observed in the lethal albino deletion homozygous mice. However, the high degree of specificity of the defects in fetal and newborn livers of lethal albino deletion homozygotes, on both ultrastructural and biochemical levels (1, 2), makes it appear very unlikely that FAH enzyme deficiency itself could cause the entire spectrum of abnormalities. In this connection, it appears particularly significant that the effect on the chromatin of the TAT promoter described here is also highly specific, since other nuclease-hypersensitive sites in TAT and the a-fetoprotein gene (Figs. 4 and 5 
